BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27853067)

  • 1. Surgical Resection for Hepatocellular Carcinoma with Cardiac Cirrhosis after the Fontan Procedure.
    Takuma Y; Fukada Y; Iwadou S; Miyatake H; Uematsu S; Okamoto R; Sato D; Matsukawa H; Shiozaki S; Kamada M; Morito T; Araki Y
    Intern Med; 2016; 55(22):3265-3272. PubMed ID: 27853067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
    J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of carcinosarcoma of the liver using Gd-EOB-DTPA.
    Yasutake T; Kiryu S; Akai H; Watadani T; Akahane M; Tomizawa N; Gonoi W; Ikemura M; Takahashi M; Matsuoka Y; Ohtomo K
    Magn Reson Med Sci; 2014; 13(2):117-21. PubMed ID: 24769633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of hypovascular lesions on dynamic computed tomography and/or gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Gyoda Y; Imamura H; Ichida H; Yoshimoto J; Ishizaki Y; Kuwatsuru R; Kawasaki S
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1242-1248. PubMed ID: 30345571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Perform Curative Laparoscopic Hepatectomy for Intraoperatively Unidentified Hepatocellular Carcinoma.
    Tsunematsu M; Onda S; Yanagaki M; Okui N; Uwagawa T; Yasuda J; Furukawa K; Haruki K; Gocho T; Toyama Y; Ikegami T
    Anticancer Res; 2021 Sep; 41(9):4411-4416. PubMed ID: 34475062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
    Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
    J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Education and imaging. Hepatobiliary and Pancreatic: Detection of early hepatocellular carcinoma by enhanced magnetic resonance imaging.
    Eso Y; Marusawa H; Osaki Y
    J Gastroenterol Hepatol; 2012 Feb; 27(2):416. PubMed ID: 22260287
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of Fontan procedure-related hepatocellular carcinoma: pure laparoscopic approach by low and stable pneumoperitoneum.
    Yokota Y; Noda T; Kobayashi S; Matsumoto K; Sakano Y; Iwagami Y; Tomimaru Y; Akita H; Gotoh K; Umeshita K; Doki Y; Eguchi H
    BMC Surg; 2020 Apr; 20(1):80. PubMed ID: 32316959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.
    Wells ML; Hough DM; Fidler JL; Kamath PS; Poterucha JT; Venkatesh SK
    Abdom Radiol (NY); 2017 Nov; 42(11):2623-2631. PubMed ID: 28785785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma: precursor nodules on pre-procedural gadoxetic acid-enhanced liver magnetic resonance imaging.
    Song KD; Rhim H; Lee MW; Kim YS; Kang TW
    Acta Radiol; 2017 Jul; 58(7):778-785. PubMed ID: 27903759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of nonenhancing lesions incidentally detected during the diagnosis of hepatocellular carcinoma.
    Ebisawa K; Midorikawa Y; Higaki T; Nakayama H; Tsuji S; Nishimaki H; Haradome H; Abe O; Sugitani M; Moriyama M; Takayama T
    Surgery; 2016 Sep; 160(3):654-60. PubMed ID: 27267550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
    Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
    J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma with indocyanine green excretory defect: a case report and review of the literature.
    Liu W; Chen LJ; Jiang Y; Xu LJ; Qiu X
    J Int Med Res; 2021 Apr; 49(4):3000605211004025. PubMed ID: 33845602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatocellular carcinoma as an incidental hepatic finding: approach to incidental focal hepatic lesions].
    Ratia Giménez T; Domínguez Franjo P; Mugüerza Huguet JM; Enríquez Navascues JM; Lasa Unzúe I; Díez Alonso M; Granell Vicent J
    Rev Esp Enferm Dig; 1996 May; 88(5):373-7. PubMed ID: 8764548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct clinicopathological phenotype of hepatocellular carcinoma with ethoxybenzyl-magnetic resonance imaging hyperintensity: association with gene expression signature.
    Miura T; Ban D; Tanaka S; Mogushi K; Kudo A; Matsumura S; Mitsunori Y; Ochiai T; Tanaka H; Tanabe M
    Am J Surg; 2015 Sep; 210(3):561-9. PubMed ID: 26105803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of hepatocellular carcinoma after Fontan operation: three case reports and review of the literature.
    Shiraishi J; Itoh S; Tomino T; Yoshiya S; Nagao Y; Kayashima H; Harada N; Sakamoto I; Tsutsui H; Yoshizumi T
    Clin J Gastroenterol; 2023 Aug; 16(4):559-566. PubMed ID: 37046144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.